Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

Nirsevimab also reduced respiratory syncytial virus (RSV) positivity and paediatric intensive care unit (PICU) admissions. Nirsevimab showed 53.5% adjusted effectiveness in reducing bronchiolitis ...

With the RSV season officially underway in South Africa, experts are urging healthcare providers to prepare for an influx of ...

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a common, contagious virus affecting the lungs and breathing passages. It usually causes mild, cold-like symptoms that are often ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

The Malinauskas Labor Government is keeping South Australian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting ...

has issued a decision amending the marketing authorization for ABRYSVO ®, the company’s bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine, to extend the indication to ...

The Allan Labor Government is keeping Victorian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting immunisation ...